Helen Palmer

If there was ever a good time to have high cholesterol, this might be it. The patent on the cholesterol-lowering statin drug, Zocor, expires today. So, generics will soon hit the market, bringing prices down. Helen Palmer reports.

Today Merck's blockbuster cholesterol-lowering drug Zocor loses its patent. Usually when a brand drug goes generic, the price drops sharply. But Merck's not giving up market share without a fight. Helen Palmer reports.

Researchers report that a drug commonly used to treat heart disease might also help lessen the debilitating effects of stroke. But getting it to market as a stroke drug might be difficult. Helen Palmer reports.

Now that Bill Gates is devoting himself to philanthropic efforts, could he become the next John D. Rockefeller? Helen Palmer reports on what his changed role could mean to health care.

A new report says the number of doctors graduating from medical school is not keeping pace with the health care needs of US patients. Why aren't people getting their MDs? Helen Palmer reports.

The American Medical Association yesterday urged restaurants and food manufactures to cut their use of salt in half to help prevent high blood pressure and heart disease. Helen Palmer reports.

Did you know that there are hundreds of unapproved prescription drugs on the market? Some pose a health threat. So now the Food and Drug Administration is cracking down. Helen Palmer reports.

The No. 3 US fast-food chain announced it's switching cooking oil to significantly reduce trans-fats in french fries and chicken items. But will customers like it? Helen Palmer reports.

Children's Hospital of Philadelphia plans to create a genetic database of over 100,000 children. The initiative raises questions about privacy and who should profit from such information. Helen Palmer reports.

The disease has claimed 25 million lives and cost billions of dollars to fight and treat. Helen Palmer looks at what the next 25 years might bring.